Afroj T - Search Results

1

Identification of fibrocyte cluster in tumors reveals the role in antitumor immunity by PD-L1 blockade.

Mitsuhashi A, Koyama K, Ogino H, Afroj T, Nguyen NT, Yoneda H, Otsuka K, Sugimoto M, Kondoh O, Nokihara H, Hanibuchi M, Takizawa H, Shinohara T, Nishioka Y. Mitsuhashi A, et al. Among authors: afroj t. Cell Rep. 2023 Mar 28;42(3):112162. doi: 10.1016/j.celrep.2023.112162. Epub 2023 Mar 3. Cell Rep. 2023. PMID: 36870329 Free article.

2

A case of pulmonary pleomorphic carcinoma with malignant phenotypes induced by ZEB1-associated epithelial-mesenchymal transition.

Kondo M, Ogino H, Ogawa H, Afroj T, Toyoda Y, Sakaguchi S, Tsuboi M, Bando Y, Goto H, Tsuneyama K, Nishioka Y. Kondo M, et al. Among authors: afroj t. Respir Med Case Rep. 2018 Aug 3;25:119-121. doi: 10.1016/j.rmcr.2018.07.008. eCollection 2018. Respir Med Case Rep. 2018. PMID: 30112272 Free PMC article.

3

Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes.

Afroj T, Mitsuhashi A, Ogino H, Saijo A, Otsuka K, Yoneda H, Tobiume M, Nguyen NT, Goto H, Koyama K, Sugimoto M, Kondoh O, Nokihara H, Nishioka Y. Afroj T, et al. J Immunol. 2021 Mar 15;206(6):1204-1214. doi: 10.4049/jimmunol.2000909. Epub 2021 Jan 27. J Immunol. 2021. PMID: 33504617 Free PMC article.

4

Programmed death (PD)-1/PD-ligand 1 blockade mediates antiangiogenic effects by tumor-derived CXCL10/11 as a potential predictive biomarker.

Mitsuhashi A, Kondoh K, Horikawa K, Koyama K, Nguyen NT, Afroj T, Yoneda H, Otsuka K, Ogino H, Nokihara H, Shinohara T, Nishioka Y. Mitsuhashi A, et al. Among authors: afroj t. Cancer Sci. 2021 Dec;112(12):4853-4866. doi: 10.1111/cas.15161. Epub 2021 Oct 23. Cancer Sci. 2021. PMID: 34628702 Free PMC article.

5

Analysis of the chemotactic factors for tumor-infiltrating fibrocytes and their prognostic significances in lung cancer.

Tobiume M, Mitsuhashi A, Saijo A, Ogino H, Afroj T, Ogawa H, Goto H, Sato S, Abe A, Haji K, Ozaki R, Takizawa H, Nishioka Y. Tobiume M, et al. Among authors: afroj t. Oncol Lett. 2022 Sep 30;24(5):417. doi: 10.3892/ol.2022.13537. eCollection 2022 Nov. Oncol Lett. 2022. PMID: 36245829 Free PMC article.

6

S-1 eliminates MDSCs and enhances the efficacy of PD-1 blockade via regulation of tumor-derived Bv8 and S100A8 in thoracic tumor.

Nguyen NT, Mitsuhashi A, Ogino H, Kozai H, Yoneda H, Afroj T, Sato S, Nokihara H, Shinohara T, Nishioka Y. Nguyen NT, et al. Among authors: afroj t. Cancer Sci. 2023 Feb;114(2):384-398. doi: 10.1111/cas.15620. Epub 2022 Nov 11. Cancer Sci. 2023. PMID: 36285504 Free PMC article.

7

CD47 promotes peripheral T cell survival by preventing dendritic cell-mediated T cell necroptosis.

Komori S, Saito Y, Nishimura T, Respatika D, Endoh H, Yoshida H, Sugihara R, Iida-Norita R, Afroj T, Takai T, Oduori OS, Nitta E, Kotani T, Murata Y, Kaneko Y, Nitta R, Ohnishi H, Matozaki T. Komori S, et al. Among authors: afroj t. Proc Natl Acad Sci U S A. 2023 Aug 15;120(33):e2304943120. doi: 10.1073/pnas.2304943120. Epub 2023 Aug 7. Proc Natl Acad Sci U S A. 2023. PMID: 37549290 Free PMC article.

8

Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse models.

Saito Y, Iida-Norita R, Afroj T, Refaat A, Hazama D, Komori S, Ohata S, Takai T, Oduori OS, Kotani T, Funakoshi Y, Koma YI, Murata Y, Yakushijin K, Matsuoka H, Minami H, Yokozaki H, Manz MG, Matozaki T. Saito Y, et al. Among authors: afroj t. Front Immunol. 2023 Dec 14;14:1294814. doi: 10.3389/fimmu.2023.1294814. eCollection 2023. Front Immunol. 2023. PMID: 38162643 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page